Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Rachel Freedman, MD, MPH

Dana-Farber Cancer Institute

Presented by #LightUpMBC Ambassador team in Memory of Gail Weisbrot

LIFT UP-Optimizing Care and Support for Women with Metastatic Breast Cancer Who Need it Most

JANET FUNK, MD

University of Arizona Cancer Center

Improving Survival in Stage IV Breast Cancer by Targeting Dormant Breast Cancer Cells in Bone

KATHLEEN GALLO, PhD

Michigan State University

Deciphering and Targeting Signaling Nodes that Drive Metastatic Breast Cancer

ANA GARRIDO-CASTRO, MD

Dana-Farber Cancer Institute

Identifying predictive biomarkers of response to PD-1 inhibition in metastatic triple-negative breast cancer

Melanie Hayden Gephart, MD, MAS

Stanford University

Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC

Identification of Race-Specific Tumor-Immune Interactions in Breast-to-Brain Metastases of Black Women

MELANIE HAYDEN GEPHART, MD, MAS

Leland Stanford Junior University

Halting the Progression of Breast Cancer Leptomeningeal Brain Metastases

Antonio Giordano, MD, PhD

Medical University of South Carolina

Presented In Honor of Michael Kovarik by 2019 New York Fashion Week

Phase 1 clinical trial of Polo-like kinase 1 inhibition with nab-paclitaxel in TP53 mutated metastatic triple negative breast ca

TODD GIORGIO, PhD

Vanderbilt University

Quantitative Characterization of Anti-Tumor Immune Response in Metastatic Breast Cancer Induced by Focused Ultrasound

Candece L. Gladson, MD

Cleveland Clinic

FIP200 promotes survival through autophagy of metastatic breast cancer in the brain

ANDREI GOGA, MD, PhD

University of California, San Francisco

Targeting the MYC Pathway in Metastatic Breast Cancer

Ana Gomes, PhD

H. Lee Moffitt Cancer Center & Research Institute

Presented in memory of Molly B. Taylor

Metabolic vulnerabilities of dormant disseminated breast cancer cells

JORGE GOMEZ DEZA, MRES, PHD

Lewis Katz School of Medicine at Temple University & Fox Chase Cancer Center

Blocking axon injury signaling to prevent chemotherapy-induced peripheral neuropathy